News
2.1 Million COVID Vaccine Doses Given in U.S.
December 29, 2020
The number is based on the CDC’s Vaccine Tracking System and reports from state and local public health departments, as well as updates from five federal agencies.
News
CDC issues COVID-19 vaccine guidance for underlying conditions
December 29, 2020
The CDC guidance had specific information for people with HIV, weakened immune systems, and autoimmune conditions such as Guillain-Barré syndrome and Bell’s palsy.
News
Scant risk for SARS-CoV-2 from hospital air
December 28, 2020
Everywhere they look within hospitals, researchers find RNA from SARS-CoV-2 in the air. But viable viruses typically are found only close to patients.
News
New resilience center targets traumatized health care workers
December 28, 2020
“It’s been grueling but we learned how to care of ourselves so we can take care of our patients,” said Joe Ciavarro, a PA at Mount Sinai.
News
COVID-19 mortality rates declined, but vary by hospital
December 24, 2020
“[T]he characteristic that is most associated with poor or worsening hospital outcomes is high or increasing community case rates,” writes David A. Asch, MD.
News
Hospital volumes start to fall again, even as COVID-19 soars
December 24, 2020
There was a much bigger crash in admissions, observation visits, and ED visits last spring than in November.
News
Moderna’s COVID-19 vaccine deemed ‘highly effective,’ but further studies needed
December 23, 2020
The primary safety endpoint was to characterize the safety of the vaccine following one or two doses.
News
Child abuse visits to EDs declined in 2020, but not admissions
December 23, 2020
Proportion of visits related to child abuse and neglect that resulted in hospitalizations increased from 2019 to 2020.
News
Call to arms: vaccinating the health workforce of 21 million strong
December 23, 2020
The real story of the debut of COVID-19 vaccination is more methodical than monumental, a celebration of teamwork.
News
COVID-19 anticoagulation trials ‘paused’ for futility, safety
December 22, 2020
The trials involved are the REMAP-CAP, ACTIV-4, and ATTACC studies.